Showing results (51-60 of 714) with videos related to

Sort By:
Pageof 72
The American Journal of Cardiology|November 14, 2006
Critical pathways using platelet testing to potentially optimize the use of oral antiplatelet therapyChristopher P Cannon, Dalton S McLean
Journal of the American College of Cardiology|May 16, 2006
Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factorsEli V Gelfand, Christopher P Cannon
Nature Clinical Practice. Cardiovascular Medicine|July 29, 2006
Update on lipid-lowering therapy and LDL-cholesterol targetsStephen D Wiviott, Christopher P Cannon
Expert Opinion on Pharmacotherapy|June 15, 2005
Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trialsKausik K Ray, Christopher P Cannon
Journal of the American College of Cardiology|October 18, 2005
The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromesKausik K Ray, Christopher P Cannon
European Heart Journal|May 15, 2015
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the futureYuichi J Shimada, Christopher P Cannon
Current Treatment Options in Cardiovascular Medicine|March 24, 2007
Lipid-independent pleiotropic effects of statins in the management of acute coronary syndromesKausik K Ray, Christopher P Cannon
Pageof 72